-
Mashup Score: 0Advances in Sickle Cell Disease - 13 hour(s) ago
Dr. Smith-Whitley, pediatric hematologist at the Children’s Hospital of Philadelphia, discusses the advances in sickle cell disease.
Source: CheckRare.comCategories: General Medicine News, Rare DiseaseTweet
-
Mashup Score: 2
For hematologic malignancy (HM) patients admitted to the ICU, survival is 49 percent at seven days and 21 percent at 12 months.
Source: CheckRare.comCategories: General Medicine News, Onc News and JournalsTweet
-
Mashup Score: 0
Incremental cost-effectiveness ratios were $126,000 and $281,000 per QALY for two simulation models from a societal perspective.
Source: CheckRare.comCategories: General Medicine News, Rare DiseaseTweet
-
Mashup Score: 1Loader - 4 day(s) ago
We have noticed an unusual activity from your IP 199.16.157.180 and blocked access to this
Source: CheckRare.comCategories: General Medicine News, Onc News and JournalsTweet
-
Mashup Score: 0Treatment With NALL Beneficial for Niemann-Pick Disease - 6 day(s) ago
Treatment with NALL for 12 weeks yields better neurological status than placebo among patients with Niemann-Pick disease type C.
Source: CheckRare.comCategories: General Medicine News, Rare DiseaseTweet
-
Mashup Score: 1Rare Disease Impact on Understanding Common Diseases - 6 day(s) ago
Cat Lutz, PhD, MBA, VP at JAX Rare Disease Translational Center, discusses rare disease research’s impact on understanding common diseases.
Source: CheckRare.comCategories: General Medicine News, Rare DiseaseTweet
-
Mashup Score: 1Personalizing Pharmaceutical Care Through AI - 6 day(s) ago
Bill Grambley explains how his company attacks health inequalities by providing personalized pharmaceutical care with an AI based platform.
Source: CheckRare.comCategories: General Medicine News, Onc News and JournalsTweet
-
Mashup Score: 1Loader - 6 day(s) ago
We have noticed an unusual activity from your IP 192.133.77.15 and blocked access to this
Source: CheckRare.comCategories: General Medicine News, Onc News and JournalsTweet
-
Mashup Score: 0Loader - 6 day(s) ago
We have noticed an unusual activity from your IP 199.16.157.181 and blocked access to this
Source: CheckRare.comCategories: General Medicine News, Rare DiseaseTweet
-
Mashup Score: 1LDRTC Symposium: Newborn Screening and Lysosomal Disorders - 6 day(s) ago
This symposium, led by Ozlem Goker-Alpan, MD of the Lysosomal & Rare Disorders Research & Treatment Center (LDRTC) reviews the current state of newborn screening (NBS) for lysosomal disorders and the need for newer guidelines to address the many unmet needs.
Source: CheckRare.comCategories: General Medicine News, Onc News and JournalsTweet
Kim Smith-Whitley, MD, discusses recent advances in sickle cell disease treatment #CheckRare #RareDisease #SickleCellDisease https://t.co/n2rW0OH5d7